View Author
Poller, W.C.
( W.C. Poller)
cgk ii cgk i iec-cf 7 cells protein expression infection iec-cf cardiomyocyte 125 i efflux 5cmvpla ad 5cmvplas activity promoter 72 hours efflux activation 2 uptake activity effect heart ad-cgk 5cmvpl figure control pl protein vector channel membrane adenoviru antisense cftr cl channels serca phosphorylation ad 5anfplas plasmid 8- pcpt-cgmp experiment kinase 2 transients serca 2 pcpt-cgmp ad-cgk ii myocyte 0.05 transfer pl cdna adenoviral study increase erasmus mc jonge ad 5cmvpls ad-cgk i 48 hours 5anfpla university uptake sarcoplasmic reticulum response lohmann cgmp-dependent forskolin adenovector analog patch level pl mrna vaandrager induction-by-disease gene therapy ad 5cmvpls cells sarcoplasmic contrast particle pig cgk ii jarchau walter hypertrophy cgmp analogs 8- br-pet-cgmp transient erasmu
2 Most Recent Publications
|
Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter
(Article)
Eizema, K. Fechner, H. Bezstarosti, K. Schneider-Rasp, S. Laarse, A. van der Wang, H. Schultheiss, H.P. Poller, W.C. Lamers, J.M.J. |
2000-01-01
|
|
cGMP stimulation of cystic fibrosis transmembrane conductance regulator Cl- channels co-expressed with cGMP-dependent protein kinase type II but not type Ibeta
(Article)
Vaandrager, A.B. Lohmann, S.M. Jarchau, T. Walter, U. Jonge, H.R. de Poller, W.C. Tilly, B.C. Smolenski, A. Schneider-Rasp, S. Bot, A.G. Edixhoven, M.J. Scholte, B.J. |
1997-01-01
|
